CRBN and Miyoshi myopathy: In our study, thalidomide and pomalidomide did not affect the ubiquitination of cereblon in RPMI8226 MM cells (Figure 5F), indicating that the protein may not be the primary pharmacological target of thalidomide or pomalidomide.